Results 261 to 270 of about 2,928,478 (311)
Some of the next articles are maybe not open access.
Radiology, 1952
In the last few years we have all witnessed with varying degrees of interest a tremendous increase in the upper limits of supravoltage energies for possible therapeutic application. A variety of radiations have become available, some in adequate quantity for the first time. We have been using a 24,000,000-volt betatron which yields a very powerful beam
R A, HARVEY, L L, HAAS, J S, LAUGHLIN
openaire +2 more sources
In the last few years we have all witnessed with varying degrees of interest a tremendous increase in the upper limits of supravoltage energies for possible therapeutic application. A variety of radiations have become available, some in adequate quantity for the first time. We have been using a 24,000,000-volt betatron which yields a very powerful beam
R A, HARVEY, L L, HAAS, J S, LAUGHLIN
openaire +2 more sources
Personalized Medicine, 2005
Karol Sikora is the Scientific Director of Medical Solutions Plc and Special Advisor to HCA International in the creation of the London Cancer Group - the largest UK cancer network outside the NHS in HCA's six major London private hospitals. This includes the construction of a major new international cancer center for care, teaching and research in ...
openaire +2 more sources
Karol Sikora is the Scientific Director of Medical Solutions Plc and Special Advisor to HCA International in the creation of the London Cancer Group - the largest UK cancer network outside the NHS in HCA's six major London private hospitals. This includes the construction of a major new international cancer center for care, teaching and research in ...
openaire +2 more sources
Journal of Psychosomatic Research, 1983
Medical technology has not reduced the death rate from cancer for 50 yrs, in spite of its physical and psychological morbidity. A broader approach is required and investigation of certain apparently successful unorthodox holistic cancer therapies suggests that the personality of the therapist is crucial.
openaire +2 more sources
Medical technology has not reduced the death rate from cancer for 50 yrs, in spite of its physical and psychological morbidity. A broader approach is required and investigation of certain apparently successful unorthodox holistic cancer therapies suggests that the personality of the therapist is crucial.
openaire +2 more sources
Apoptosis, cancer and cancer therapy
Surgical Oncology, 1997Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis. Apoptosis is essential in the homeostasis of normal tissues of the body, especially those of the gastrointestinal tract, immune system and ...
R J, Bold, P M, Termuhlen, D J, McConkey
openaire +2 more sources
Primary Care: Clinics in Office Practice, 1992
The chemotherapeutic treatment of cancer has evolved into a major treatment modality. Better results than ever before are being recorded with the integration of this approach into the early and total management of cancer. Although complex and toxic, these drugs and their combinations are contributing in new ways to the treatment of more and more ...
openaire +2 more sources
The chemotherapeutic treatment of cancer has evolved into a major treatment modality. Better results than ever before are being recorded with the integration of this approach into the early and total management of cancer. Although complex and toxic, these drugs and their combinations are contributing in new ways to the treatment of more and more ...
openaire +2 more sources
Glycoconjugates in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry, 2008This review focuses on recent efforts in glycoconjugate construction for the creation and evaluation of vaccines based on carbohydrate cancer-associated antigens. This therapeutic approach takes advantage from the known tendency of transformed cells to express selective carbohydrate motifs otherwise hidden in normal cells. The immunological response is
CIPOLLA, LAURA FRANCESCA +2 more
openaire +2 more sources
Cold Spring Harbor Perspectives in Medicine
Significant advances in basic and translational research have improved our understanding of the molecular alterations and biological vulnerabilities of the different histologic subsets of epithelial ovarian cancer (EOC). This has led to clinical trials that have incorporated novel agents based on molecular aspects into the treatment paradigm for both ...
Diana, Miao +2 more
openaire +2 more sources
Significant advances in basic and translational research have improved our understanding of the molecular alterations and biological vulnerabilities of the different histologic subsets of epithelial ovarian cancer (EOC). This has led to clinical trials that have incorporated novel agents based on molecular aspects into the treatment paradigm for both ...
Diana, Miao +2 more
openaire +2 more sources
Seminars in Cancer Biology, 2004
Like most embryonic tissues, tumors have the ability to build up their own blood vessel networks. However, the architecture of tumor vessels is fundamentally different from that found in healthy tissues. Tumor vessels are usually irregular, heterogeneous, leaky, and poorly associated with mural cells.
openaire +2 more sources
Like most embryonic tissues, tumors have the ability to build up their own blood vessel networks. However, the architecture of tumor vessels is fundamentally different from that found in healthy tissues. Tumor vessels are usually irregular, heterogeneous, leaky, and poorly associated with mural cells.
openaire +2 more sources
Annals of Nuclear Medicine, 1998
Therapeutic nuclear medicine is rapidly developing as an additional treatment modality in oncology. Its unique characteristics are the systemic, yet selective delivery of radiation doses in target tissues, its non-invasiveness, the relative lack of immediate and late side effects, and the advantage that uptake and retention in the tumor can be pre ...
openaire +2 more sources
Therapeutic nuclear medicine is rapidly developing as an additional treatment modality in oncology. Its unique characteristics are the systemic, yet selective delivery of radiation doses in target tissues, its non-invasiveness, the relative lack of immediate and late side effects, and the advantage that uptake and retention in the tumor can be pre ...
openaire +2 more sources
Nature Reviews Drug Discovery, 2010
Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies. In 2009, ~16,000 of the ~40,000 Phase I, II and III trials listed on ClinicalTrials.gov were related to cancer (~40%). This large interest stems from the existence of high unmet need for improved treatments of multiple types of cancer and the substantial ...
openaire +2 more sources
Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies. In 2009, ~16,000 of the ~40,000 Phase I, II and III trials listed on ClinicalTrials.gov were related to cancer (~40%). This large interest stems from the existence of high unmet need for improved treatments of multiple types of cancer and the substantial ...
openaire +2 more sources